Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics

Cancer is a complex disease; glioblastoma (GBM) is no exception. Short survival, poor prognosis, and very limited treatment options make it imperative to unravel the disease pathophysiology. The critically important identification of proteins that mediate various cellular events during disease is ma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Physiol Genomics
Autori principali: Heroux, Maxime S., Chesnik, Marla A., Halligan, Brian D., Al-Gizawiy, Mona, Connelly, Jennifer M., Mueller, Wade M., Rand, Scott D., Cochran, Elizabeth J., LaViolette, Peter S., Malkin, Mark G., Schmainda, Kathleen M., Mirza, Shama P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Physiological Society 2014
Soggetti:
General Interest
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587597/
https://ncbi.nlm.nih.gov/pubmed/24803679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/physiolgenomics.00034.2014
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi